Skip to content
Screener

Total Equity at other companies

Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$31.71B+5.9%
Opus Genetics logo
Opus GeneticsIRD
-$45.84M-1,004%
Regenxbio logo
RegenxbioRGNX
$71.77M-66.4%
Relay Therapeutics, Inc. logo
Relay Therapeutics, Inc.RLAY
$890.01M+33.7%
Prime Medicine logo
Prime MedicinePRME
$39.81M-34.6%
4D Molecular Therapeutics logo
4D Molecular TherapeuticsFDMT
$451.84M-3.8%

Other financials

Income statement

See full
Revenue$293.0K-84.8%
Operating income-$40.8M+1.9%
Net income-$46.3M-15.8%
EPS (diluted)-$0.57-11.8%

Balance sheet

See full
Cash & equivalents$71.5M+7.5%
Total debt$62.7M-22.5%
Total assets$244.7M+9.2%

Cash flow

See full
Operating cash flow$17.8M+148%
CapEx$2.0M+17.4%
Free cash flow$15.8M+141%

Valuation

See full
Market cap$1.18B+85.4%
Enterprise value$1.18B+71.1%
P/S14.9×-2.0×

Profitability

See full
Operating margin-597.9%-207pp
Net margin-615.3%
FCF margin-441.5%-126pp

Returns & leverage

See full
Return on equity-379.5%
Debt / equity27.2×+26.1×
Current ratio0.5×-1.0×

Where this comes from

Reported directly by MeiraGTx Holdings plc in its filing.

Tagged under the XBRL concept us-gaap:StockholdersEquity.

The source filing: MeiraGTx Holdings plc’s 10-Q, filed May 14, 2026.

Filed
May 14, 2026, 8:30 AM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001104659-26-060739
Line itemMarch 31, 2026December 31, 2025
SHAREHOLDERS' DEFICIT:
Ordinary Shares, $0.00003881 par value, 1,288,327,750 authorized, 81,446,126 and 81,120,931 shares issued and outstanding at March 31, 2026 and December 31, 2025, respectively33
Capital in excess of par value820,018808,021
Treasury shares(18,193)
Accumulated other comprehensive gain2,5782,406
Accumulated deficit(862,536)(816,223)
Total Shareholders' Deficit(58,130)(5,793)
TOTAL LIABILITIES AND SHAREHOLDERS' DEFICIT$244,655$244,430

Item 1. Financial Statements (Unaudited)

FAQ

What is MeiraGTx Holdings plc's total equity?
MeiraGTx Holdings plc (MGTX) reported total equity of -$58.13M in Q1 2026.
How has MeiraGTx Holdings plc's total equity changed year-over-year?
MeiraGTx Holdings plc's total equity decreased by 275.6% year-over-year, from $33.1M to -$58.13M.
What is the long-term trend for MeiraGTx Holdings plc's total equity?
Over 5 years (2020 to 2025), MeiraGTx Holdings plc's total equity has grown at a -52.5% compound annual growth rate (CAGR), from $238.56M to -$5.79M.
What does total equity mean?
Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.

Ask your AI about MeiraGTx Holdings plc's total equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude